S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Athene Holding Ltd. stock logo
ATH
Athene
$83.33
$82.69
$40.21
$91.26
$16.01B1.691.28 million shs3.50 million shs
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
$1.44
+33.3%
$1.06
$0.91
$1.67
N/A0.3955,873 shs912,417 shs
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.05
$0.05
$0.25
$3.56
$1.42M2.34455,220 shs44,803 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Athene Holding Ltd. stock logo
ATH
Athene
0.00%0.00%0.00%0.00%0.00%
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
-1.82%-4.42%+4.85%+8.00%+4.81%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00%+7.07%+3.63%+11.11%-99.25%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/AN/AN/AN/AN/A
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/AN/AN/AN/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/A
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Athene Holding Ltd. stock logo
ATH
Athene
$14.76B1.08$9.00 per share9.26$105.33 per share0.79
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
$150KN/A$0.05 per share29.25$0.89 per shareN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$18.16M0.08N/AN/A$1.94 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Athene Holding Ltd. stock logo
ATH
Athene
$1.54B$18.944.409.09N/A13.69%14.35%1.40%N/A
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
-$20K-$0.03N/AN/A-13.82%-0.46%-0.45%5/8/2024 (Estimated)
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/A

Latest OPHR, ATH, GBR, CVN, and SQZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/A-$0.04-$0.04-$0.04N/A$0.04 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/AN/A
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Athene Holding Ltd. stock logo
ATH
Athene
0.11
0.65
0.65
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/A
6.12
6.12
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/A
3.50
3.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Athene Holding Ltd. stock logo
ATH
Athene
85.87%
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
38.51%

Insider Ownership

CompanyInsider Ownership
Athene Holding Ltd. stock logo
ATH
Athene
6.80%
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
2.10%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
16.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Athene Holding Ltd. stock logo
ATH
Athene
1,350192.14 million179.08 millionOptionable
New Concept Energy, Inc. stock logo
GBR
New Concept Energy
3N/AN/ANot Optionable
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
5329.49 million24.77 millionNot Optionable

OPHR, ATH, GBR, CVN, and SQZ Headlines

SourceHeadline
VC funding update: who raised money in March?VC funding update: who raised money in March?
bizjournals.com - April 1 at 11:06 AM
SQZ, Portal founder Armon Sharei on starting over in biotechSQZ, Portal founder Armon Sharei on starting over in biotech
biopharmadive.com - March 26 at 10:35 AM
Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
finance.yahoo.com - March 19 at 10:20 AM
SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to StemcellSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell
fiercebiotech.com - March 1 at 10:56 AM
Rx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and moreRx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and more
mmm-online.com - February 16 at 8:05 AM
SQZB SQZ Biotechnologies CompanySQZB SQZ Biotechnologies Company
seekingalpha.com - December 28 at 1:42 PM
SQZ Biotechnologies Co Ordinary Shares SQZBSQZ Biotechnologies Co Ordinary Shares SQZB
morningstar.com - December 12 at 8:37 PM
SQZ founder Armon Sharei opens Portal to to simplify intracellular deliverySQZ founder Armon Sharei opens Portal to to simplify intracellular delivery
fiercebiotech.com - December 12 at 10:35 AM
Medicine at a bigger scale: FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site'Medicine at a bigger scale': FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site
wral.com - November 11 at 8:41 PM
‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%
fiercebiotech.com - November 9 at 10:34 AM
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - November 8 at 6:33 PM
SQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0M
msn.com - November 8 at 6:33 PM
Lifeline Biotechnologies Inc LLBOLifeline Biotechnologies Inc LLBO
morningstar.com - November 4 at 11:41 PM
SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 3 at 7:42 PM
SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - August 10 at 9:16 PM
Sqz Biotechnologies Co (SQZB)Sqz Biotechnologies Co (SQZB)
investing.com - August 3 at 7:45 AM
Roche declines to take up option on SQZ Bio’s SQZ-APC-HPV programRoche declines to take up option on SQZ Bio’s SQZ-APC-HPV program
thepharmaletter.com - July 27 at 12:11 AM
Roche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ BiotechnologiesRoche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ Biotechnologies
precisionmedicineonline.com - July 25 at 10:53 PM
Roche Decides Not to Exercise Solid Tumor Option with SQZRoche Decides Not to Exercise Solid Tumor Option with SQZ
biospace.com - July 25 at 10:53 PM
SQZ Biotechnologies Provides Update on Collaboration with RocheSQZ Biotechnologies Provides Update on Collaboration with Roche
benzinga.com - July 25 at 12:37 PM
Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurchRoche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch
pharmaceutical-technology.com - July 25 at 12:37 PM
Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)
knoxdaily.com - July 5 at 1:10 PM
SQZ Biotechnologies to be delisted from the NYSESQZ Biotechnologies to be delisted from the NYSE
seekingalpha.com - July 3 at 11:23 PM
NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)
finance.yahoo.com - July 3 at 6:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Athene logo

Athene

NYSE:ATH
Athene Holding Ltd. is engages in the provision of retirement services. The firm issues, reinsures and acquires retirement savings products and institutional products. It operates through following segments: Retirement Services, and Corporate and Other. The Retirement Services segment is comprised of US and Bermuda operations, which issue and reinsure retirement savings products and institutional products. The Corporate and Other segment includes corporate activities such as corporate allocated expenses, merger and acquisition costs, debt costs, preferred stock dividends, certain integration and restructuring costs, certain stock-based compensation and intersegment eliminations. The company was founded by James R. Belardi and Frank L. Gills in May 2009 and is headquartered in Pembroke, Bermuda.
New Concept Energy logo

New Concept Energy

NYSE:GBR
New Concept Energy, Inc. engages in real estate rental business. The company owns approximately 190 acres of land located in Parkersburg West Virginia. It also provides advisory and management services for an independent oil and gas company. The company was formerly known as CabelTel International Corporation and changed its name to New Concept Energy, Inc. in May 2008. New Concept Energy, Inc. is based in Dallas, Texas.
SQZ Biotechnologies logo

SQZ Biotechnologies

NYSE:SQZ
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.